Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately 25% of the global population [1] , and 20-30% of these cases progress to a more severe stage known as MASH [2]
The most notable study is the STEP 1 trial, a randomized, double-masked, placebo-controlled study published in the New England Journal of Medicine
Helping your body tap into fat stores can preserve glycogen for later in the race
It works by activating fat breakdown while preventing new fat formation
It contains a potent blend of vitamins, including Cyanocobalamin (Vitamin B12), Hydroxycobalamin, Vitamin B15, Biothine (Vitamin H), and liver extract, which collectively support various physiological functions
For example, insurance coverage may also influence treatment patterns